Publication | Open Access
Theranostics of Malignant Melanoma with <sup>64</sup>CuCl<sub>2</sub>
96
Citations
32
References
2014
Year
Both melanotic and amelanotic melanomas (B16F10 and A375M) tested were found to overexpress CTR1. The tumors can be successfully visualized by (64)CuCl2 PET and further treated by (64)CuCl2, highlighting the high potential of using (64)CuCl2 as a theranostic agent for the management of melanoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1